BX vs RARE · P/E 33, rev $5.04B vs rev $350.0M
Blackstone Group Inc (BX) versus Ultragenyx (RARE) — a side-by-side from cached financials, not a winner call.
Blackstone Group Inc (BX) is a asset management company listed on NYSE.
Ultragenyx (RARE) is a biotechnology company listed on US.
Latest reported BX revenue for 2026-06-30 was $5.04B. Net income was $1.23B. Revenue was up 39.4% from 2026-03-31 to 2026-06-30. BX currently screens at market cap $156.29B and trailing P/E 32.8.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
BX currently screens at market cap $156.29B and trailing P/E 32.8. RARE currently screens at market cap $2.79B.
Not investment advice. Open the BX and RARE stock pages for the full models.
Not investment advice.